IL6 and autoimmune disease: Thus, our findings highlight the possible biological relevant ligand for IL-6R, which is of great importance for filling out the current knowledge of the IL-6/IL-6R/gp130 buffer system, and provide a potential inhibitor for clinical application in autoimmune diseases.